Celgene Corporation

(NASDAQ:CELG)

52.60

+1.76 (3.46%)

Dec 03 - Close

Open
50.10
High
52.89
Low
49.27
Vol.
4.20M
Mkt Cap
24.10B
52Wk High
77.39
52Wk Low
41.26
Avg. Vol.
5.88M
P/E (Trailing)
-16.18
Beta
0.92
Short %
1.80%
Div. Yield
—

After-Hours 52.55 -0.05 (-0.10%) Wed, 3 Dec 2008 5:40 PM

Company Profile

Celgene Corporation

86 Morris Avenue

Summit, NJ 07901

United States - Map

Phone: (908) 673-9000

Fax: (908) 673-9001

Website: www.celgene.com

State of incorporation: Delaware

CEO: Dr. Sol J. Barer, Ph.D.

Employees: 1,685

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biophamaceutical co. focused on cancer therapies

A biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Recent news for CELG

Recent opinions on CELG

No recent Opinions for CELG

Top members owning CELG

Members owning CELG also own

GE (16.28%), T (9.30%), EBAY (9.30%), SNDK (9.30%), MCD (9.30%)

Member sentiment: Neutral